dengue treatment market insights, dengue treatment market forecast, dengue treatment market research, dengue treatment industry share, dengue treatment market analysis, dengue treatment market trends
What is the current size and annual growth rate of the dengue treatment market?
The dengue treatment market size has grown rapidly in recent years. It will grow from $2.10 billion in 2024 to $2.35 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to improved diagnostic tools, government and NGO efforts, epidemiological surveillance systems, significant investments in r&d and community education initiatives.
The dengue treatment market size is expected to see rapid growth in the next few years. It will grow to $3.64 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to development of universal vaccines, expanding vaccine availability, public-private partnerships, telemedicine growth and policy framework enhancements. Major trends in the forecast period include next-generation dengue vaccines, AI-based drug discovery, smart contact tracing tools, 3D-printed vaccines and crispr for virus targeting.
Get Your Free Sample of The Global Dengue Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20745&type=smp
Which major factors have contributed to the expansion of the dengue treatment market?
The rising dengue incidence rate is expected to propel the growth of the dengue treatment market going forward. Dengue refers to a mosquito-borne viral infection that causes flu-like symptoms and can develop into severe complications if untreated. The rising dengue incidence rate is primarily due to increased urbanization, climate change favoring mosquito breeding, inadequate vector control measures, and population growth in high-risk areas. Dengue treatment reduces the incidence rate of dengue by ensuring timely medical intervention, alleviating severe symptoms, preventing complications, and curbing the disease’s spread through better patient outcomes and enhanced public health awareness. For instance, according to a report published by the Centers for Disease Control and Prevention, a US-based government agency, in 2023, dengue fever cases in the Americas surged to over 4.6 million, with approximately 4,000 deaths, marking a 13% increase from the same period in 2022 and a significant rise from previous years. Therefore, the rising dengue incidence rate is driving the growth of the dengue treatment market.
How is the dengue treatment market segmented?
The dengue treatment market covered in this report is segmented –
1) By Type: Vaccines, Acetaminophen
2) By Route Of Administration: Parenteral, Oral
3) By Drug Class: Nsaids, Antibiotics, Corticosteroids
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospital, Specialty Clinics, Home Healthcare
Subsegments:
1) By Vaccines: Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines
2) By Acetaminophen: Oral Acetaminophen, Intravenous Acetaminophen
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/dengue-treatment-global-market-report
Who are the top competitors in the dengue treatment market?
Major companies operating in the dengue treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., Sanofi S.A., Abbott Laboratories, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Limited, Cipla Incorporated, Emergent BioSolutions Inc., Bharat Biotech International Limited, Inovio Pharmaceuticals Inc., Gennova Biopharmaceuticals Ltd., ABIVAX S.A., Cadila Healthcare Limited, Biological E. Limited
Which key trends are expected to influence the dengue treatment market in the coming years?
Major companies operating in the dengue treatment market are focusing on developing solutions such as broad-spectrum antiviral drugs to enhance treatment efficacy, reduce disease severity, and address multiple serotypes of the dengue virus simultaneously. A broad-spectrum antiviral drug refers to a medication that is effective against a wide range of viruses, rather than targeting a specific virus. For instance, in September 2024, Hyundai Pharmaceutical Co. Ltd., a South Korea-based manufacturer of pharmaceutical products, launched XAFTY, a groundbreaking broad-spectrum antiviral designed to treat multiple viral infections, including COVID-19, and dengue fever. It offers unique features such as an innovative drug that enhances the absorption and effectiveness of niclosamide, proven safety and efficacy demonstrated in clinical trials, the ability to target a range of RNA viruses, providing versatility against potential future threats, and a rapid response potential that allows for expedited supply to regions facing public health crises.
Which regional trends are influencing the dengue treatment market, and which area dominates the industry?
Asia-Pacific was the largest region in the dengue treatment in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dengue treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Dengue Treatment Market Report 2025 Offer?
The dengue treatment market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Dengue treatment refers to the medical management and supportive care provided to individuals infected with the dengue virus, transmitted by Aedes mosquitoes. Dengue treatment utilizes supportive care measures, such as fever management with paracetamol, hydration through oral or intravenous fluids, and close monitoring for complications like bleeding or shock, ensuring timely intervention to aid recovery.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20745
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
